Skip to main content

Advertisement

Log in

Cytopathology of Follicular Cell Nodules

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

This article corresponds to a lecture delivered during the Endocrine Pathology Society symposium held in Boston on 21 March 2015 (104th USCAP meeting, March 21–27). It focuses on the importance of cytopathology in endocrine thyroid pathology and the limits and pitfalls of diagnosis in follicular cell lesions. Lights and shadows are present in each diagnostic technique: Fine needle aspiration has imposed itself as a gold standard in thyroid nodules thanks to its easiness of execution and high cost-effectiveness ratio. A milestone in this field is represented by the National Cancer Institute (NCI) Thyroid Fine Needle Aspiration (FNA) State of the State of the Science Conference hosted in October 22–23, 2007 by the NCI, followed by a series of documents published in Diagnostic Cytopathology and Cytojournal (2008) as well as in an atlas entitled: The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC): terminology and criteria (2010, Springer). “Gray” zones still remain, causing difficulties and anxiety to the cytopathologist when facing challenging cases. Each diagnostic category of TBSRTC is analyzed and discussed in a concise fashion with special emphasis on challenging cases such as atypia of undetermined significance (AUS), suspicion for follicular neoplasms (SFNs), diagnoses of papillary thyroid carcinoma (PTC) in Hashimoto thyroiditis and follicular variant of papillary carcinoma (FVPTC). Our aim was to better define and clarify the spectrum of follicular cell lesions in thyroid nodule samplings and to underline the diagnostic limits in order to avoid pitfalls. New emerging molecular biology techniques may represent useful tools in selected morphological challenging cases and lead to new therapeutic approaches in line with drug-tailored therapy and personalized medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Russ G, Bigorgne C, Royer B, Rouxel A, Bienvenu-Perrard M. The Thyroid Imaging Reporting and Data System (TIRADS) for ultrasound of the thyroid. J Radiol. 92(7–8):701–713, 2011.

    Article  CAS  PubMed  Google Scholar 

  2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19:1167–1214, 2009.

    Article  PubMed  Google Scholar 

  3. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology: definitions, criteria and explanatory notes. New York, NY: Springer, 2010.

    Book  Google Scholar 

  4. Guidance on the reporting of thyroid cytology specimens. The Royal College of Pathologists. Review in November 2011; http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/G/g089guidanceonthereportingofthyroidcytologyfinal.pdf . Accessed 30th May 2015

  5. Nardi F., Basolo F., Crescenzi A., et al. Italian consensus for the classification and reporting of thyroid cytology. Journal of Endocrinol Invest. 37(6):593–599,2014.

    Article  Google Scholar 

  6. Kocjan G, Cochand-Priollet B, de Agustin PP, Bourgain C, Chandra A, Daneshbod Y, Deery A, Duskova J, Ersoz C, Fadda G, Fassina A, Firat P, Jimenez-Ayala B, Karakitsos P, Koperek O, Matesa N, Poller D, Thienpont L, Ryska A, Schenck U, Sauer T, Schmitt F, Tani E, Toivonen T, Tötsch M, Troncone G, Vass L, Vielh P. Diagnostic terminology for reporting thyroid fine needle aspiration cytology: European Federation of Cytology Societies thyroid working party symposium, Lisbon 2009. Cytopathology. 21(2):86–92, 2010.

    Article  CAS  PubMed  Google Scholar 

  7. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe. Cochand-Priollet B, Schmitt FC, Tötsch M, Vielh P; European Federation of Cytology Societies’ Scientific Committee. Acta Cytol. 55(6):507–11,2011.

    Article  CAS  PubMed  Google Scholar 

  8. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med. 371(19):1765–1767, 2014.

    Article  PubMed  Google Scholar 

  9. Vanderlaan WP. The occurence of carcinoma of the thyroid gland in autopsy material. N Engl J Med 237:221–222, 1947.

    Article  CAS  PubMed  Google Scholar 

  10. Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch HG, Hwang S, Berry DA, Kinzler KW, Black WC, Bissell M, Parnes H, Srivastava S. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 15(6):234–42, 2014.

    Article  Google Scholar 

  11. Gibelli B, Dionisio R, Ansarin M. Role of hemithyroidectomy in differentiated thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 23(2):99–106, 2015.

    Article  PubMed  Google Scholar 

  12. Stelow EB, Bardales RH, Crary GS, Gulbahce HE, Stanley MW, Savik K, Pambuccian SE. Interobserver variability in thyroid fine-needle aspiration interpretation of lesions showing predominantly colloid and follicular groups. Am J Clin Pathol. Aug;124(2):239–44, 2005.

  13. Cibas ES, Baloch ZW, Fellegara G, LiVolsi VA, Raab SS, Rosai J, Diggans J, Friedman L, Kennedy GC, Kloos RT, Lanman RB, Mandel SJ, Sindy N, Steward DL, Zeiger MA, Haugen BR, Alexander EK. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 159(5):325–332, 2013.

    Article  PubMed  Google Scholar 

  14. Elsheikh TM, Asa SL, Chan JK, DeLellis RA, Heffess CS, LiVolsi VA, Wenig BM. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 130(5):736–44, 2008.

    Article  PubMed  Google Scholar 

  15. Kholová I, Ludvíková M. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage? Acta Cytol. 58(4):319–29,2014.

    Article  PubMed  Google Scholar 

  16. Spectrum of follicular nuclear size and amount of colloid in follicular lesions of the thyroid. Thyroid Cytopathology: an atlas and text. Kini SR, Wolters & Kluwer Health, 2nd ed, 2015.

  17. Lee J, Hasteh F. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto’s thyroiditis: a case report and review of the literature. Diagn Cytopathol. 37(8):600–606, 2009.

    Article  PubMed  Google Scholar 

  18. Roh MH, Jo VY, Stelow EB, Faquin WC, Zou KH, Alexander EK, Larsen PR, Marqusee E, Benson CB, Frates MC, Gawande A, Moore FD Jr, Cibas ES. The predictive value of the fine-needle aspiration diagnosis “suspicious for a follicular neoplasm, Hürthle cell type” in patients with Hashimoto thyroiditis. Am J Clin Pathol. 135(1):139–45, 2011.

    Article  PubMed  Google Scholar 

  19. Baloch ZW, LiVolsi VA. Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology. Endocr. Pathol. 25:12–20, 2014.

    Article  CAS  PubMed  Google Scholar 

  20. Auger M. Hürthle Cells in Fine-Needle Aspirates of the Thyroid Cancer Cytopathol.;122(4):241–249, 2014.

    Article  PubMed  Google Scholar 

  21. Ghossein R. Update to the College of American Pathologists Reporting on Thyroid Carcinomas. Head Neck Pathol. 3(1):86–93, 2009.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer. Lancet.;381(9871):1058–69, 2013.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Lastra RR, Pramick MR, Crammer CJ, LiVolsi VA, Baloch ZW. Implications of a suspicious Afirma test result in thyroid fine-needle aspiration cytology: an institutional experience. Cancer Cytopathol.122(10):737–744, 2014.

    Article  PubMed  Google Scholar 

  24. Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer. 120(23):3627–3634, 2014.

    Article  CAS  PubMed  Google Scholar 

  25. Choi SH, Baek JH, Lee JH, Choi YJ, Hong MJ, Song DE, Kim JK, Yoon JH, Kim WB. Thyroid nodules with initially non-diagnostic, fine-needle aspiration results: comparison of core-needle biopsy and repeated fine-needle aspiration. Eur Radiol.;24(11):2819–2826, 2014.

    Article  PubMed  Google Scholar 

  26. Yi KS, Kim JH, Na DG, Seo H, Min HS, Won JK, Yun TJ, Ryoo I, Kim SC, Choi SH, Sohn CH. Usefulness of Core Needle Biopsy for Thyroid Nodules with Macrocalcifications: Comparison with Fine-Needle Aspiration Thyroid 2015. doi:10.1089/thy.2014.0596.

    PubMed  Google Scholar 

  27. Paja M, Del Cura JL, Zabala R, Corta I, Lizarraga A, Oleaga A, Expósito A, Gutiérrez MT, Ugalde A, López JI. Ultrasound-guided core-needle biopsy in thyroid nodules. A study of 676 consecutive cases with surgical correlation. Eur Radiol. doi 10.1007/s00330-015-3821-1, 2015.

    PubMed  Google Scholar 

  28. Yoon R, Baek JH, Lee JH, Choi YJ, Hong MJ, Song DE, Kim JK, Yoon JH, Kim WB. Diagnosis of thyroid follicular neoplasm: fine-needle aspiration versus core-needle biopsy. Thyroid. 24(11):1612–1617, 2014.

    Article  PubMed  Google Scholar 

  29. Fadda G, Rossi ED, Raffaelli M, Pontecorvi A, Sioletic S, Morassi F, Lombardi CP, Zannoni GF, Rindi G. Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur J Endocrinol. 165(3):447–453, 2011.

    Article  CAS  PubMed  Google Scholar 

  30. Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R. Thyroid;21(10):1067–73, 2011.

    Article  CAS  PubMed  Google Scholar 

  31. Lastra RR, LiVolsi VA, Baloch ZW. Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist’s perspective. Cancer Cytopathol.;122(7):484–503, 2014.

    Article  PubMed  Google Scholar 

  32. Cheng S, Serra S, Mercado M, Ezzat S, Asa SL. A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res. 15;17(8):2385–2394, 2011.

  33. Xing M, Haugen BR, Schlumberger M. Progress in molecular-based management of differentiated thyroid cancer. Lancet. 23;381(9871):1058–69, 2013.

  34. Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, Pitoia F, Pacini F. Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diabetes Endocrinol. 2(5):356–8, 2014.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philippe Vielh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Damiani, D., Suciu, V. & Vielh, P. Cytopathology of Follicular Cell Nodules. Endocr Pathol 26, 286–290 (2015). https://doi.org/10.1007/s12022-015-9386-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-015-9386-3

Keywords

Navigation